Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Biomarker/Laboratory analysis, Treatment				Active				18 and under				NICHD				PPRU 10762 NCT00491946

Last Modified: 10/6/2008 First Published: 8/18/2006


2.		Phase III Randomized Study of Glutamic Acid in Reducing Vincristine-Related Peripheral Neurotoxicity in Young Patients Undergoing Vincristine-Containing Treatment for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Active				3 to 20				NCI				MCC-0402 NCT00369564, ACCL 0731

Last Modified: 9/29/2008 First Published: 7/7/2006


3.		Phase III Study of Adjuvant Vincristine and Dactinomycin With or Without Doxorubicin Hydrochloride and Radiotherapy or Observation Only in Younger Patients Who are Undergoing Nephrectomy for Newly Diagnosed Stage I-III Favorable Histology Wilms' Tumor

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 30 at diagnosis				NCI				COG-AREN0532 AREN0532, NCT00352534

Last Modified: 6/6/2008 First Published: 6/2/2006


4.		Phase II Study of Combination Chemotherapy, Radiotherapy, and/or Surgery in Patients With High-Risk Renal Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				30 and under				NCI				COG-AREN0321 AREN0321, NCT00335556


5.		Topotecan, Ifosfamide and Carboplatin in Children and Young Adults With Solid Tumors

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Active				45 and under				Other				2004-0079 NCT00502892


6.		Respiratory Tumor and Normal Tissue Motion

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Natural history/Epidemiology, Treatment				Active				Not specified				Other				2003-0962 NCT00415675

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute